Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 38.5b

13 Nov 2015 12:07

RNS Number : 6882F
GoldmanSachs International
13 November 2015
Ā 

Ap27

Ā 

Ā 

FORMĀ 38.5(b)

Ā 

IRISHĀ TAKEOVERĀ PANEL

Ā 

DISCLOSUREĀ UNDERĀ RULEĀ 38.5(b)Ā OFĀ THEĀ IRISHĀ TAKEOVERĀ PANEL ACT,Ā 1997,Ā TAKEOVERĀ RULES,Ā 2013

Ā 

DEALINGSĀ BYĀ CONNECTEDĀ EXEMPTĀ PRINCIPALĀ TRADERSĀ WITHOUTĀ RECOGNISEDĀ INTERMEDIARYĀ STATUS,Ā ORĀ WITHĀ RECOGNISEDĀ INTERMEDIARYĀ STATUSĀ BUTĀ NOTĀ DEALINGĀ INĀ AĀ CLIENT-SERVINGĀ CAPACITY

Ā 

Ā 

1. KEYĀ INFORMATION

Ā 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD ordinary & GDR

Date of dealing

12 November 2015

Ā 

2. INTERESTS AND SHORT POSITIONS

Ā 

(a) InterestsĀ andĀ shortĀ positionsĀ (followingĀ dealing)Ā inĀ theĀ classĀ ofĀ relevantĀ securityĀ dealtĀ inĀ (NoteĀ 2)

Ā 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

1,404,803 (0.02)

45,998 (0.00)

(2) Derivatives (other than options)

0 (0.00)

Ā 0 (0.00)

(3) Options and agreements to purchase/sell

0 (0.00)

Ā 0 (0.00)

Total

1,404,803 (0.02)

45,998 (0.00)

Ā 

(b) InterestsĀ andĀ shortĀ positionsĀ inĀ relevantĀ securitiesĀ ofĀ theĀ company,Ā otherĀ thanĀ theĀ classĀ dealtĀ inĀ (NoteĀ 2)

Ā 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap28

Ā 

Ā 

3. DEALINGSĀ (NoteĀ 3)

Ā 

(a) PurchasesĀ andĀ sales

Ā 

Purchase/sale

Number of relevant securities

Price per unit (Note 4)

Purchase (Borrow New)

922,557

N/A

Sale (Borrow Full Return)

912,369

N/A

Purchase (Borrow New)

10,188

N/A

Sale (Borrow Full Return)

10,188

N/A

Purchase (Borrow Adjust)

337

N/A

Purchase (Borrow Adjust)

326

N/A

Purchase (Borrow Adjust)

465

N/A

Purchase (Borrow Adjust)

450

N/A

Purchase (Borrow Adjust)

657

N/A

Purchase (Borrow Adjust)

635

N/A

Purchase (Borrow Adjust)

217

N/A

Purchase (Borrow Adjust)

209

N/A

Sale (Borrow Partial Return)

11

N/A

Sale (Borrow Partial Return)

315

N/A

Sale (Borrow Partial Return)

675

N/A

Sale (Borrow Partial Return)

15

N/A

Sale (Borrow Partial Return)

433

N/A

Sale (Borrow Partial Return)

928

N/A

Sale (Borrow Partial Return)

22

N/A

Sale (Borrow Partial Return)

613

N/A

Sale (Borrow Partial Return)

1,314

N/A

Sale (Borrow Partial Return)

7

N/A

Sale (Borrow Partial Return)

202

N/A

Sale (Borrow Partial Return)

433

N/A

Ā 

(b) DerivativesĀ transactionsĀ (otherĀ thanĀ optionsĀ transactions)

Ā 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

Ā 

Ā 

(c) OptionsĀ transactionsĀ inĀ respectĀ ofĀ existingĀ relevantĀ securities

Ā 

Ā 

(i) Writing,Ā selling,Ā purchasingĀ orĀ varying

Ā 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

Ā 

Ā 

(ii) Exercising

Ā 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

Ā 

Ā 

(d) OtherĀ dealingsĀ (includingĀ transactionsĀ inĀ respectĀ ofĀ newĀ securities)Ā (NoteĀ 3)

Ā 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

Ā 

Ā 

Ap29

Ā 

OTHERĀ INFORMATION

Ā 

Agreements,Ā arrangementsĀ orĀ understandingsĀ relatingĀ toĀ optionsĀ orĀ derivatives

Ā 

FullĀ detailsĀ ofĀ anyĀ agreement,Ā arrangementĀ orĀ understandingĀ betweenĀ theĀ person disclosingĀ andĀ anyĀ otherĀ personĀ relatingĀ toĀ theĀ votingĀ rightsĀ ofĀ anyĀ relevantĀ securitiesunderĀ anyĀ optionĀ referredĀ toĀ onĀ thisĀ formĀ orĀ relatingĀ toĀ theĀ votingĀ rightsĀ orĀ futureĀ acquisitionorĀ disposalĀ ofĀ anyĀ relevantĀ securitiesĀ toĀ whichĀ anyĀ derivative referredĀ toĀ onĀ thisĀ formĀ isĀ referenced.IfĀ none,Ā thisĀ shouldĀ beĀ stated.

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

IsĀ aĀ SupplementalĀ FormĀ 38.5(b)Ā attached?Ā (NoteĀ 8) Ā YES/NO

Ā 

Ā 

Date of disclosure

13 November 2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 9)

Advisor to Offeror

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
ISEEAAFDFEASFFF
Date   Source Headline
1st Mar 20178:51 amRNSPress Release
27th Feb 201710:45 amRNSPress Release
24th Feb 20172:19 pmRNSPress Release
22nd Feb 20177:00 amRNSCancellation of UK Listing
31st Jan 20172:56 pmRNSFourth Quarter and Full-Year 2016 Results
24th Nov 20153:20 pmRNSForm 8.3 - Pfizer Inc
24th Nov 20153:19 pmRNSForm 8.3 - Pfizer, Inc.
24th Nov 201512:14 pmRNSForm 38.5(b) - Pfizer Inc
24th Nov 201511:49 amRNSForm 8.1a - Pfizer Inc
24th Nov 201511:46 amRNSForm 38.5(a) - Pfizer Inc
24th Nov 201510:41 amRNSRule 38.5 - Pfizer INC
24th Nov 20157:00 amRNSForm 38.5(b) - Pfizer Inc
23rd Nov 20156:11 pmRNSForm 38.5(a) - Pfizer Inc
23rd Nov 20155:58 pmRNSForm 8.1a - Pfizer Inc
23rd Nov 20153:40 pmRNSForm 8.3 - PFIZER INC
23rd Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc Amendment
23rd Nov 20153:31 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20153:31 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20153:28 pmRNSForm 8.3 - ALLERGAN PLC
23rd Nov 20153:21 pmRNSForm 8.3 - Pfizer, Inc.
23rd Nov 20152:56 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20152:39 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20152:29 pmRNSForm 8.3 - Allergan Plc
23rd Nov 201512:16 pmRNSForm 8.1 - [Pfizer Inc.]
23rd Nov 201512:04 pmRNSForm 38.5a
23rd Nov 201511:57 amRNSForm 38.5b
23rd Nov 201511:55 amRNSForm 38.5b
23rd Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
23rd Nov 201510:58 amRNSRule 38.5 - Pfizer INC
23rd Nov 201510:58 amRNSRule 38.5 - Pfizer INC
20th Nov 20153:43 pmRNSForm 8.3 - Pfizer Inc.
20th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20153:25 pmRNSForm 8.3 - Allergan plc
20th Nov 20153:21 pmRNSForm 8.3 - PFIZER INC
20th Nov 20153:17 pmRNSForm 8.3 - ALLERGAN PLC
20th Nov 20153:14 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20153:11 pmRNSForm 8.3 - [PFIZER INC]
20th Nov 20153:07 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20152:58 pmRNSForm 8.3 - Allergan plc
20th Nov 20152:57 pmRNSRule 38.5 - Replacement Pfizer INC
20th Nov 20152:52 pmRNSForm 8.3 - Allergan Plc
20th Nov 20152:44 pmRNSForm 8.3 - Pfizer, Inc.
20th Nov 201512:14 pmRNSForm 8.1 - [Pfizer Inc]
20th Nov 201511:57 amRNSForm 38.5b
20th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
20th Nov 201511:53 amRNSForm 38.5b
20th Nov 201511:53 amRNSForm 38.5(b) - Pfizer Inc
20th Nov 201511:52 amRNSForm 38.5a
20th Nov 201511:18 amRNSForm 38.5(a) - Pfizer Inc
20th Nov 201510:37 amRNSRule 38.5 - Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.